Study identification

EU PAS number

EUPAS107688

Study ID

107689

Official title and acronym

Mirikizumab Pregnancy Registry (I6T-MC-B006)

DARWIN EU® study

No

Study countries

United States

Study description

Mirikizumab Pregnancy Registry

Study status

Planned
Research institutions and networks

Institutions

Contact details

Francis Mawanda

Primary lead investigator
Study timelines

Date when funding contract was signed

Actual:

Study start date

Planned:

Date of final study report

Planned:
Sources of funding
Pharmaceutical company and other private sector 

More details on funding

Eli Lilly &amp, Co.
Regulatory

Was the study required by a regulatory body?

Yes

Is the study required by a Risk Management Plan (RMP)?

Not applicable